EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Effects of Nucleotide-Rich Kluyveromyces fragilis and Saccharomyces cerevisiae Yeast Extracts on Cognitive Function in Older Adults with Mild Cognitive Impairment: A Randomized Placebo-Controlled Trial

Hammad Ullah iD, Marcello Cordara, Maria Vittoria Morone iD, Roberto Piccinocchi, Lorenza Francesca De Lellis, Angela Cerqua, Alessandra Baldi iD, Roberto Sacchi iD, Gaetano Piccinocchi iD, Alessandro Di Minno iD, Gaia Spadarella, Maria Daglia iD

Nutrients · 10.06.2026 · 18 (12) · 1869

DOI: 10.3390/nu18121869 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, online erschienen am 10.06.2026. Verfasst von Hammad Ullah und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, COMSATS University Islamabad, Abbottabad Campus, Abbottabad 22060, Pakistan. Hauptthemen laut MEDLINE: Saccharomyces cerevisiae, Kluyveromyces, Cognitive Dysfunction, Cognition. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Mild cognitive impairment (MCI) may precede dementia, and safe nutritional strategies able to support cognitive function are of clinical interest. Dietary nucleotides may contribute to membrane phospholipid synthesis, synaptic function, and neuroprotective pathways; however, clinical evidence in older adults with MCI remains limited. This randomized placebo-controlled trial evaluated the efficacy and tolerability of nucleotide-rich yeast extracts from Kluyveromyces fragilis and Saccharomyces cerevisiae.

Methods

Seventy-two participants (mean age 73.5 ± 7.7 years; range 60–85) were randomly assigned (1:1:1) to receive K. fragilis extract, S. cerevisiae extract, or placebo once daily for 180 days. Cognitive outcomes were assessed using the Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) at baseline (T0), 90 days (T1), and 180 days (T2); quality of life was assessed using the SF-12 questionnaire at T0 and T2. Treatment effects were analyzed using linear mixed-effects models adjusted for age and sex.

Results

After 180 days, MoCA scores increased by 4.42 points in the K. fragilis group and 3.92 points in the S. cerevisiae group, compared with 0.58 points in the placebo group (time × treatment p < 0.001; T0–T2 within-group p < 0.001 for both active groups and p = 0.14 for placebo). MMSE scores increased by 1.62 and 3.11 points in the K. fragilis and S. cerevisiae groups, respectively, compared with 0.25 points in the placebo group (time × treatment p < 0.001; T0–T2 within-group p < 0.001 for both active groups and p = 0.57 for placebo). The SF-12 mental component score increased by 7.50 and 9.16 points in the two active groups, respectively (time × treatment p = 0.022; T0–T2 p = 0.0013 and p < 0.001, respectively), while physical quality-of-life scores did not change significantly (PCS time × treatment p = 0.11). No adverse events were reported.

Conclusions

Nucleotide-rich K. fragilis and S. cerevisiae yeast extracts were well tolerated and were associated with improved cognitive scores over six months in older adults with MCI. Larger multicenter trials are needed to confirm these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Saccharomyces cerevisiaeKluyveromycesCognitive DysfunctionCognitionNucleotidesHumansMaleAgedFemaleAged, 80 and overMiddle AgedCognitive EnhancementDouble-Blind MethodDietary SupplementsQuality of LifeTreatment Outcome

Stichwörter der Autor:innen

aging brainfood-derived bioactivesmental well-beingnutraceuticalspsychometric assessment

Substanzen

Nucleotides

Autor:innen und Institutionen

  • Department of Pharmacy, COMSATS University Islamabad, Abbottabad Campus, Abbottabad 22060, Pakistan.
  • School of Medicine, University of Milano-Bicocca, 20126 Milan, Italy.
  • Department of Pharmacy, University of Napoli Federico II, 80131 Naples, Italy.
  • Anaesthesia and Resuscitation A. U. O. Luigi Vanvitelli, 80138 Naples, Italy.
  • Applied Statistic Unit, Department of Earth and Environmental Sciences, University of Pavia, 27100 Pavia, Italy.
  • Comegen S.C.S., Società Cooperativa Sociale, 80125 Naples, Italy.

ORCID-Profile: Hammad Ullah, Maria Vittoria Morone, Alessandra Baldi, Roberto Sacchi, Gaetano Piccinocchi, Alessandro Di Minno, Maria Daglia

Zitieren

APA

Ullah, H., Cordara, M., Morone, M. V., Piccinocchi, R., De Lellis, L. F., Cerqua, A., Baldi, A., Sacchi, R., Piccinocchi, G., Di Minno, A., Spadarella, G., & Daglia, M. (2026). Effects of Nucleotide-Rich Kluyveromyces fragilis and Saccharomyces cerevisiae Yeast Extracts on Cognitive Function in Older Adults with Mild Cognitive Impairment: A Randomized Placebo-Controlled Trial. Nutrients, 18(12), 1869. https://doi.org/10.3390/nu18121869

Vancouver

Ullah H, Cordara M, Morone MV, Piccinocchi R, De Lellis LF, Cerqua A, et al. Effects of Nucleotide-Rich Kluyveromyces fragilis and Saccharomyces cerevisiae Yeast Extracts on Cognitive Function in Older Adults with Mild Cognitive Impairment: A Randomized Placebo-Controlled Trial. Nutrients. 2026;18(12):1869. doi:10.3390/nu18121869

BibTeX
@article{Ullah2026,
  author = {Ullah, Hammad and Cordara, Marcello and Morone, Maria Vittoria and Piccinocchi, Roberto and De Lellis, Lorenza Francesca and Cerqua, Angela and Baldi, Alessandra and Sacchi, Roberto and Piccinocchi, Gaetano and Di Minno, Alessandro and Spadarella, Gaia and Daglia, Maria},
  title = {Effects of Nucleotide-Rich Kluyveromyces fragilis and Saccharomyces cerevisiae Yeast Extracts on Cognitive Function in Older Adults with Mild Cognitive Impairment: A Randomized Placebo-Controlled Trial},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {12},
  pages = {1869},
  doi = {10.3390/nu18121869}
}
Kostenlos starten →